EVOMEDI - About the company
EVOMEDI is an unfunded company based in Potsdam (Germany), founded in 2017. It operates as a Patient recruitment solution. EVOMEDI has not raised any funding yet. The company has 1406 active competitors, including 341 funded and 184 that have exited. Its top competitors include companies like Verily, IQVIA and Innovaccer.
Company Details
EVOMEDI provides patient recruitment solution. It offers integrated patient identification and recruitment solutions to find the right patient at the right time for a trial to accelerate clinical trial outcomes. It helps to improve patient experiences and engagement levels.
- Website
- evomedi.com
- Email ID
- *****@evomedi.com
- Phone Number
- +49 **********
Key Metrics
Sign up to download EVOMEDI's company profile
EVOMEDI's funding and investors
EVOMEDI has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
EVOMEDI's Competitors and alternates
Top competitors of EVOMEDI include Verily, IQVIA and Innovaccer. Here is the list of Top 10 competitors of EVOMEDI, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
2nd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
3rd |  Innovaccer 2014, San Francisco (United States), Series F | Developer of healthcare data platforms and artificial intelligence agent software | $675M | 78/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 77/100 | |
5th | Manifold AI 2016, Oakland (United States), Series B | Provider of an AI platform for life sciences research and development | $40M | 72/100 | |
6th |  Evidation 2012, Menlo Park (United States), Series E | Real-world health data insights for better healthcare decisions and research | $259M | 70/100 | |
7th | Hyro 2014, New York City (United States), Series C | Provider of an AI-based conversational platform | $115M | 70/100 | |
8th |  Inspiren 2016, Brooklyn (United States), Series C | AI based patient monitoring system for healthcare professionals | $225M | 69/100 | |
9th |  Artera 2021, Menlo Park (United States), Series A | AI-derived prognostic biomarker test for cancer detection | $135M | 68/100 | |
10th | myTomorrows 2012, Amsterdam (Netherlands), Series C | Platform provides access to drugs in development to patients and physicians | $51.3M | 67/100 | |
937th | Patient recruitment solution | - | - | 24/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on EVOMEDI's competitors? Click here to see the top ones
EVOMEDI's Investments and acquisitions
EVOMEDI has made no investments or acquisitions yet.
Reports related to EVOMEDI
Here is the latest report on EVOMEDI's sector:
Are you a Founder ?
FAQs about EVOMEDI
Explore our recently published companies
- ARTNEST AGENCY - ARTIST - Munich based, 2023 founded, Unfunded company
- Rainkraft - Bengaluru based, 2015 founded, Unfunded company
- BOZ - The Woodlands based, 2009 founded, Unfunded company
